Literature DB >> 26129790

A β-lactamase inhibitor revival provides new hope for old antibiotics.

Ken Garber.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26129790     DOI: 10.1038/nrd4666

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  4 in total

Review 1.  Antibiotic resistance breakers: current approaches and future directions.

Authors:  Mark Laws; Ali Shaaban; Khondaker Miraz Rahman
Journal:  FEMS Microbiol Rev       Date:  2019-09-01       Impact factor: 16.408

2.  VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in Enterobacterales and Pseudomonas aeruginosa.

Authors:  Jodie C Hamrick; Jean-Denis Docquier; Tsuyoshi Uehara; Cullen L Myers; David A Six; Cassandra L Chatwin; Kaitlyn J John; Salvador F Vernacchio; Susan M Cusick; Robert E L Trout; Cecilia Pozzi; Filomena De Luca; Manuela Benvenuti; Stefano Mangani; Bin Liu; Randy W Jackson; Greg Moeck; Luigi Xerri; Christopher J Burns; Daniel C Pevear; Denis M Daigle
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

3.  Discovery of [1,2,4]Triazole Derivatives as New Metallo-β-Lactamase Inhibitors.

Authors:  Chen Yuan; Jie Yan; Chen Song; Fan Yang; Chao Li; Cheng Wang; Huiling Su; Wei Chen; Lijiao Wang; Zhouyu Wang; Shan Qian; Lingling Yang
Journal:  Molecules       Date:  2019-12-23       Impact factor: 4.411

4.  Discovery of mercaptopropanamide-substituted aryl tetrazoles as new broad-spectrum metallo-β-lactamase inhibitors.

Authors:  Yu-Hang Yan; Jian Chen; Zhen Zhan; Zhu-Jun Yu; Gen Li; Li Guo; Guo-Bo Li; Yong Wu; Yongxiang Zheng
Journal:  RSC Adv       Date:  2020-08-25       Impact factor: 3.361

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.